Research & Development



  “這就是名將的樣子?名將等于不喜歡說話,一說話就能把人噎死?”曹襄不甘心的對雲瑯道。   老虎丟下那根牛腿骨不玩了,警惕的抬起頭,雲瑯朝老虎注意的方向瞅了一眼,就看見東方朔興沖沖的朝水池子這邊跑過來。高清无码在线av短片   曹襄冷哼道︰“既然想弄死他,剛才為何故意射偏?”久久re99热在线视频   听了這話,其余三人都信服的點頭,就騙人這一項本事而言,雲瑯算得上技高一籌。   總有不服氣的,可能數量有點多,李敢在揍倒了幾個人之後,就被人群給淹沒了……一级a做爰片就在线看 第八章 縱橫家跟法令

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo